Category: BIIB – Biogen Inc. Common Stock
Healthcare Review Starting In 2021 And Focus On PTH
Barrons Retirement: Eli Lilly Stock Is Surging on Hope for Alzheimer’s Drug. Analyst Says It Won’t Last.
Eli Lilly Stock Is Surging on Hope for Alzheimer’s Drug. Analyst Says It Won’t Last.
The company has said it will provide detailed data on the treatment on March 13. The stock is up some 19% over the past week.
The company has said it will provide detailed data on the treatment on March 13. The stock is up some 19% over the past week.
Eli Lilly Stock Is Surging on Hope for Alzheimer’s Drug. Analyst Says It Won’t Last.
The company has said it will provide detailed data on the treatment on March 13. The stock is up some 19% over the past week.
Company Close Updates: Biogen Inc. stock underperforms Tuesday when compared to competitors
Eli Lilly upgraded to buy at Mizuho on positive donanemab data
Top Healthcare Stocks for February 2021
These are the healthcare stocks with the best value, fastest growth, and most momentum for February 2021.
The European Commission Grants Marketing Authorization for PLEGRIDY® (peginterferon beta-1a) Intramuscular Administration for Relapsing-Remitting Multiple Sclerosis | Proteins and Peptides | News Channels – PipelineReview.com
Company Close Updates: Biogen Inc. stock falls Friday, underperforms market
The Zacks Analyst Blog Highlights: PayPal, Exxon Mobil, Goldman Sachs, Charter Communications and Biogen
The Zacks Analyst Blog Highlights: PayPal, Exxon Mobil, Goldman Sachs, Charter Communications and Biogen